[{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"MRM Health","pharmaFlowCategory":"D","therapeuticArea":"Endocrinology","country":"U.S.A","productType":"Large molecule","year":"2020","type":"Collaboration","leadProduct":"Gut microbiome based therapeutics","moa":"","graph1":"Endocrinology","graph2":"Undisclosed","graph3":"International Flavors and Fragrances","amount2":0.02,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Endocrinology","amount2New":0.02,"dosageForm":"","sponsorNew":"International Flavors and Fragrances \/ DuPont","highestDevelopmentStatusID":"1","companyTruncated":"International Flavors and Fragrances \/ DuPont"},{"orgOrder":0,"company":"International Flavors and Fragrances","sponsor":"International Flavors and Fragrances","pharmaFlowCategory":"D","therapeuticArea":"Immunology","country":"U.S.A","productType":"Large molecule","year":"2020","type":"Collaboration","leadProduct":"Gut-Microbiome","moa":"","graph1":"Immunology","graph2":"Discovery","graph3":"International Flavors and Fragrances","amount2":0,"highestDevelopmentShortName":"Discovery","therapeuticAreaShortName":"Immunology","amount2New":0,"dosageForm":"","sponsorNew":"International Flavors and Fragrances \/ DuPont","highestDevelopmentStatusID":"2","companyTruncated":"International Flavors and Fragrances \/ DuPont"}]

Find Clinical Drug Pipeline Developments & Deals by International Flavors and Fragrances

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Pharma, Lab & Chemical Expo
                          Not Confirmed
                          Pharma, Lab & Chemical Expo
                          Not Confirmed

                          Details : The two-year research partnership will focus on improving the benefit/risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to potentially improve response rates through modulation of the microbiome.

                          Brand Name : Undisclosed

                          Molecule Type : Large molecule

                          Upfront Cash : Undisclosed

                          July 23, 2020

                          Lead Product(s) : Gut-Microbiome

                          Therapeutic Area : Immunology

                          Highest Development Status : Discovery

                          Recipient : Rutgers University

                          Deal Size : Undisclosed

                          Deal Type : Collaboration

                          blank

                          02

                          Pharma, Lab & Chemical Expo
                          Not Confirmed
                          Pharma, Lab & Chemical Expo
                          Not Confirmed

                          Details : In collaboration, proprietary MRM Health technology platform and some selected DuPont strains will be combined to develop novel therapeutics based on live bacterial strain combinations.

                          Brand Name : Undisclosed

                          Molecule Type : Large molecule

                          Upfront Cash : Undisclosed

                          February 19, 2020

                          Lead Product(s) : Gut microbiome based therapeutics

                          Therapeutic Area : Endocrinology

                          Highest Development Status : Undisclosed

                          Recipient : MRM Health

                          Deal Size : $15.1 million

                          Deal Type : Collaboration

                          blank